About

Gentle products, hard science, strong team

Meet our board.

Kim Bøttkjær
Kim Bøttkjær
Chairman
Kim is Founder and managing partner of FIH PARTNERS, Denmark's leading M&A advisor. He has worked with the majority of listed biotech companies in Denmark and advised on numerous IPOs and rights issues in the biotech sector.
John Theroux
John Theroux
CEO & Director
John has served as head of the European practice of management consultants Bain and Company and as head of a number of early stage technology companies. He has also served as lecturer at the Harvard Business School.
Thierry Philardeau
Thierry Philardeau
Director
Thierry is Senior Vice President and Head of Nestle’s Nutrition Strategic Business Unit (Société des Produits Nestlé SA) since January 1, 2018. He joined Nestlé in 1986. From 2011 to 2015, he was member of the DPA Supervisory Board (Dairy Partners of America), of the GDP Board (Global Dairy Platform) as well as of the IDF Board (International Dairy Federation).
Harold Humbert
Harold Humbert
Director
Harold is a Vice President and Head of F&C of Nestlé Zone Europe, Middle East & North Africa since January 2018, joined Nestlé Waters International in 1995 and occupied various positions in Audit and Finance & Control within Nestlé. Former board member of Ecopar in France (part of the national recycling institution ECO Emballage), currently board member of Gerber Life Insurance in the US. He has a Bachelor Degree in Finance and a Master in Sales & Marketing.
Peter Rothschild
Peter Rothschild
Director
Peter Rothschild is Group President and co-founder of BioGaia AB (BIOGb.ST, Stockholm Stock Exchange), an innovative Swedish-based biotechnology company and world leader in probiotics that develops and sells probiotic products and solutions with documented health benefits.
He is Chairman of Infant Bacterial Therapeutics a listed company devloping drugs for premature babies. During the course of his career, Rothschild has held positions on the boards of directors of several companies, including Diamyd Medica and Moberg PharmaSwedish pharmaceutical.
Thomas Schweizer
Thomas Schweizer
Director
After a PhD in Chemistry and a post-doc period at the University of Basel (Switzerland) Dr. Thomas Schweizer joined the Nestlé Research Department in 1976, where he specialized in food carbohydrates and later in infant and medical nutrition. He is an author of about 40 peer-reviewed scientific papers, many resulting from international collaborations with academic institutions. From 1995 he led various Nestlé R&D units. After his retirement from Nestlé in 2009 he works as an independent consultant.
Our website uses cookies We will ask you to consent to our use of cookies in accordance with the terms of this policy read more
Ok